310 related articles for article (PubMed ID: 363461)
1. Effect of postovulatory treatment with a luteinizing hormone-releasing hormone analog on the plasma level of progesterone in women.
Koyama T; Ohkura T; Kumasaka T; Saito M
Fertil Steril; 1978 Nov; 30(5):549-52. PubMed ID: 363461
[TBL] [Abstract][Full Text] [Related]
2. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
3. Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor.
Casper RF; Yen SS
Science; 1979 Jul; 205(4404):408-10. PubMed ID: 377491
[TBL] [Abstract][Full Text] [Related]
4. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
Hutchison JS; Zeleznik AJ
Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women.
Lemay A; Faure N; Labrie F
Fertil Steril; 1982 Feb; 37(2):193-200. PubMed ID: 6800846
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
[TBL] [Abstract][Full Text] [Related]
7. Administration of luteinizing hormone-releasing hormone analogs delays ovulation without affecting the luteal function in rhesus monkeys.
Borghi MR; Niesvisky R; Balmaceda JP; Coy DH; Schally AV; Asch RH
Fertil Steril; 1983 Nov; 40(5):678-82. PubMed ID: 6414849
[TBL] [Abstract][Full Text] [Related]
8. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
9. Effect on corpus luteum function of luteal phase administration of a potent gonadotropin-releasing hormone analog (nafarelin).
Schriock ED; Monroe SE; Martin MC; Henzl MR; Jaffe RB
Fertil Steril; 1985 Jun; 43(6):844-50. PubMed ID: 3158549
[TBL] [Abstract][Full Text] [Related]
10. Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women.
Bergquist C; Nillius SJ; Wide L
Contraception; 1980 Sep; 22(3):287-93. PubMed ID: 7002443
[TBL] [Abstract][Full Text] [Related]
11. The effects of single-dose luteinizing hormone-releasing hormone on ovulatory menstrual function: support for a single luteinizing hormone- and follicle-stimulating hormone-releasing factor.
Reindollar RH; Moretuzzo RW; Ellegood JO; Mahesh VB; McDonough PG
Fertil Steril; 1985 Feb; 43(2):185-95. PubMed ID: 3917946
[TBL] [Abstract][Full Text] [Related]
12. Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.
Skarin G; Nillius SJ; Wide L
Contraception; 1982 Jan; 25(1):31-9. PubMed ID: 6800690
[TBL] [Abstract][Full Text] [Related]
13. Possible luteolytic effects of luteinizing hormone-releasing hormone in normal women.
Lemay A; Labrie F; Ferland L; Raynaud JP
Fertil Steril; 1979 Jan; 31(1):29-34. PubMed ID: 369890
[TBL] [Abstract][Full Text] [Related]
14. The induction of premature luteolysis in normal women--follicular phase luteinizing hormone secretion and corpus luteum function in the subsequent cycle.
Soules MR; Bremner WJ; Dahl KD; Rivier JE; Vale WW; Clifton DK
Am J Obstet Gynecol; 1991 Apr; 164(4):989-94; discussion 994-6. PubMed ID: 2014851
[TBL] [Abstract][Full Text] [Related]
15. Suppression of postovulatory gonadotropin levels does not affect corpus luteum function in rhesus monkeys.
Balmaceda JP; Borghi MR; Coy DH; Schally AV; Asch RH
J Clin Endocrinol Metab; 1983 Oct; 57(4):866-8. PubMed ID: 6411757
[TBL] [Abstract][Full Text] [Related]
16. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
17. Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women.
Lemay A; Labrie F; Raynaud JP
Int J Fertil; 1980; 25(3):203-12. PubMed ID: 6108931
[TBL] [Abstract][Full Text] [Related]
18. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
[TBL] [Abstract][Full Text] [Related]
20. Estrogen induces premature luteal regression in rhesus monkeys during spontaneous menstrual cycles, but not in cycles driven by exogenous gonadotropin-releasing hormone.
Hutchison JS; Kubik CJ; Nelson PB; Zeleznik AJ
Endocrinology; 1987 Aug; 121(2):466-74. PubMed ID: 3297646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
